| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q2 2026 | 85 | 518,827 | CDNA, WGS, ENSG, AMRC | 13F-HR | 8/5/2026 | 000101905626000123 |
| Q1 2026 | 85 | 433,208 | ENSG, CDNA, AMRC, WGS | 13F-HR | 4/21/2026 | 000101905626000076 |
| Q4 2025 | 86 | 491,087 | CDNA, WGS, AL, ENSG | 13F-HR | 2/12/2026 | 000101905626000037 |
| Q3 2025 | 86 | 498,503 | AL, ENSG, WGS, AMRC | 13F-HR | 11/3/2025 | 000101905625000228 |
| Q2 2025 | 87 | 492,357 | AL, ENSG, CDNA, ISRG | 13F-HR | 7/23/2025 | 000101905625000196 |
| Q1 2025 | 98 | 454,535 | AL, ENSG, ISRG, CDNA | 13F-HR | 5/9/2025 | 000101905625000173 |
| Q4 2024 | 91 | 496,305 | AL, ISRG, CDNA, ENSG | 13F-HR | 1/23/2025 | 000101905625000034 |
| Q3 2024 | 102 | 504,352 | CDNA, ENSG, AL, ISRG | 13F-HR | 11/12/2024 | 000101905624000316 |
| Q2 2024 | 97 | 443,988 | AL, CDNA, ENSG, ISRG | 13F-HR | 8/14/2024 | 000101905624000242 |
| Q1 2024 | 98 | 422,544 | AL, ENSG, CDNA, ISRG | 13F-HR | 5/13/2024 | 000101905624000169 |
| Q4 2023 | 102 | 416,585 | AL, ENSG, CDNA, ISRG | 13F-HR | 2/14/2024 | 000101905624000095 |
| Q3 2023 | 97 | 399,063 | AL, ENSG, ISRG, NVGS | 13F-HR | 11/14/2023 | 000101905623000396 |
| Q2 2023 | 97 | 480,938 | AL, ENSG, ISRG, PCRX | 13F-HR | 8/8/2023 | 000101905623000328 |
| Q1 2023 | 112 | 475,804 | AL, ENSG, NVGS, PCRX | 13F-HR | 4/10/2023 | 000101905623000201 |
| Q4 2022 | 106 | 452,942 | AL, ENSG, PCRX, NVGS | 13F-HR | 2/7/2023 | 000101905623000104 |
| Q3 2022 | 101 | 454,820 | PCRX, AL, ENSG, CDNA | 13F-HR | 11/14/2022 | 000101905622000644 |
| Q2 2022 | 101 | 477,076 | PCRX, AL, ENSG, NVGS | 13F-HR | 8/1/2022 | 000101905622000526 |
| Q1 2022 | 103 | 613,179 | PCRX, AL, CDNA, ENSG | 13F-HR | 5/9/2022 | 000101905622000377 |
| Q4 2021 | 105 | 666,799 | AL, AOSL, CDNA, PCRX | 13F-HR | 2/8/2022 | 000101905622000153 |
| Q3 2021 | 112 | 673,112 | CDNA, AL, PCRX, ENSG | 13F-HR | 11/12/2021 | 000101905621000591 |
| Q2 2021 | 111 | 704,320 | CDNA, AL, ENSG, AMRC | 13F-HR | 7/28/2021 | 000101905621000437 |
| Q1 2021 | 108 | 656,701 | CDNA, AL, ENSG, PCRX | 13F-HR | 5/14/2021 | 000101905621000301 |
| Q4 2020 | 99 | 628,130 | CDNA, AL, AMRC, ENSG | 13F-HR | 2/12/2021 | 000101905621000108 |
| Q3 2020 | 100 | 468,978 | CDNA, AL, PCRX, ENSG | 13F-HR | 11/12/2020 | 000101905620000563 |
| Q2 2020 | 91 | 412,965 | CDNA, AL, PCRX, AMRC | 13F-HR | 8/13/2020 | 000101905620000474 |
| Q1 2020 | 96 | 294,330 | CDNA, AL, ENSG, AMRC | 13F-HR | 5/11/2020 | 000101905620000313 |
| Q4 2019 | 93 | 456,867 | AL, GFN, CDNA, EVBG | 13F-HR | 2/14/2020 | 000101905620000156 |
| Q3 2019 | 95 | 422,607 | AL, CDNA, GFN, ENSG | 13F-HR | 11/8/2019 | 000101905619000636 |
| Q2 2019 | 97 | 463,774 | CDNA, AL, ENSG, EVBG | 13F-HR | 8/12/2019 | 000101905619000468 |
| Q1 2019 | 97 | 458,671 | CDNA, AL, ENSG, EVBG | 13F-HR | 5/13/2019 | 000101905619000286 |
| Q4 2018 | 93 | 376,005 | CDNA, AL, GFN, ENSG | 13F-HR | 1/18/2019 | 000101905619000021 |
| Q3 2018 | 101 | 435,126 | CDNA, GFN, AL, ENSG | 13F-HR | 11/13/2018 | 000101905618001065 |
| Q2 2018 | 97 | 346,700 | GFN, CDNA, AL, LLFLQ | 13F-HR | 8/9/2018 | 000101905618000942 |
| Q1 2018 | 95 | 280,913 | AL, RHT, GFN, CDNA | 13F-HR | 5/9/2018 | 000101905618000597 |
| Q4 2017 | 91 | 281,801 | AL, GFN, CDNA, RHT | 13F-HR | 2/13/2018 | 000101905618000332 |
| Q3 2017 | 95 | 269,005 | AL, RHT, LLFLQ, FIVN | RESTATEMENT | 11/14/2017 | 000101905617000770 |
| Q2 2017 | 89 | 360,479 | RHT, AL, LLFLQ, FIVN | 13F-HR | 7/20/2017 | 000101905617000611 |
| Q1 2017 | 95 | 231,181 | AL, LLFLQ, RHT, ATHN | 13F-HR | 5/11/2017 | 000101905617000443 |
| Q4 2016 | 96 | 233,147 | AL, RTEC, GFNSL, ATHN | 13F-HR | 2/14/2017 | 000101905617000184 |
| Q3 2016 | 97 | 234,999 | AL, ATHN, AMBR, RTEC | 13F-HR | 11/14/2016 | 000101905616001642 |
| Q2 2016 | 92 | 214,357 | ATHN, EQIX, AL, AMBR | RESTATEMENT | 8/24/2016 | 000101905616001510 |
| Q1 2016 | 88 | 208,884 | AL, ATHN, EQIX, RHT | 13F-HR | 5/3/2016 | 000101905616001288 |
| Q4 2015 | 86 | 218,359 | ATHN, RHT, AL, EQIX | 13F-HR | 2/16/2016 | 000101905616001071 |
| Q3 2015 | 88 | 204,427 | RHT, EQIX, AL, ATHN | 13F-HR | 10/16/2015 | 000101905615000817 |
| Q2 2015 | 89 | 252,756 | AL, RHT, EQIX, NVCN | 13F-HR | 7/24/2015 | 000101905615000637 |
| Q1 2015 | 93 | 301,431 | AL, NVCN, GFN, RHT | 13F-HR | 5/12/2015 | 000101905615000478 |
| Q4 2014 | 95 | 311,909 | GFN, EQIX, RHT, CTCT | 13F-HR | 2/13/2015 | 000101905615000174 |
| Q3 2014 | 99 | 299,341 | GFN, EQIX, AL, ATHN | 13F-HR | 10/15/2014 | 000101905614001315 |
| Q2 2014 | 106 | 308,944 | GFN, NVCN, AL, EQIX | 13F-HR | 7/31/2014 | 000101905614000976 |
| Q1 2014 | 104 | 336,609 | GFN, AL, ATHN, NVCN | 13F-HR | 5/6/2014 | 000101905614000638 |
| Q4 2013 | 98 | 333,057 | NVDQ, GFN, ATHN, AL | RESTATEMENT | 2/6/2014 | 000101905614000137 |
Investors who own more than 5% of a class must file a Schedule 13D or 13G.
8 securities where the latest filing since 12/18/2024 is a 13G, the newest filed 8/27/2026. View all